These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37001243)
1. Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system. Wei B; Weng N; Fu L; Li Y; Wang X; Yin R; Jiang T Bioorg Med Chem; 2023 Apr; 84():117257. PubMed ID: 37001243 [TBL] [Abstract][Full Text] [Related]
2. Myelin imaging compound (MIC) enhanced magnetic resonance imaging of myelination. Frullano L; Zhu J; Wang C; Wu C; Miller RH; Wang Y J Med Chem; 2012 Jan; 55(1):94-105. PubMed ID: 22098543 [TBL] [Abstract][Full Text] [Related]
3. A myelin-specific contrast agent for magnetic resonance imaging of myelination. Frullano L; Wang C; Miller RH; Wang Y J Am Chem Soc; 2011 Feb; 133(6):1611-3. PubMed ID: 21265506 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of a novel gadolinium-based contrast agent for magnetic resonance imaging of myelination. Frullano L; Zhu J; Miller RH; Wang Y J Med Chem; 2013 Feb; 56(4):1629-40. PubMed ID: 23311333 [TBL] [Abstract][Full Text] [Related]
5. Myelin mapping in the central nervous system of living mice using contrast-enhanced magnetization transfer MRI. Watanabe T; Frahm J; Michaelis T Neuroimage; 2012 Nov; 63(2):812-7. PubMed ID: 22796983 [TBL] [Abstract][Full Text] [Related]
6. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination. Seiwa C; Yamamoto M; Tanaka K; Fukutake M; Ueki T; Takeda S; Sakai R; Ishige A; Watanabe K; Akita M; Yagi T; Tanaka K; Asou H J Neurosci Res; 2007 Apr; 85(5):954-66. PubMed ID: 17290413 [TBL] [Abstract][Full Text] [Related]
7. In vivo quantification of myelin changes in the vertebrate nervous system. Wang Y; Wu C; Caprariello AV; Somoza E; Zhu W; Wang C; Miller RH J Neurosci; 2009 Nov; 29(46):14663-9. PubMed ID: 19923299 [TBL] [Abstract][Full Text] [Related]
8. [Protein composition and structure of the myelin sheath. Part I]. Pietrucha-Dutczak M; Marcol W; Korczyńska I; Matuszek I; Górka D; Lewin-Kowalik J Pol Merkur Lekarski; 2003 Sep; 15(87):268-72. PubMed ID: 14679855 [TBL] [Abstract][Full Text] [Related]
9. Inhomogeneous Magnetization Transfer (ihMT) imaging in the acute cuprizone mouse model of demyelination/remyelination. Hertanu A; Soustelle L; Buron J; Le Priellec J; Cayre M; Le Troter A; Prevost VH; Ranjeva JP; Varma G; Alsop DC; Durbec P; Girard OM; Duhamel G Neuroimage; 2023 Jan; 265():119785. PubMed ID: 36464096 [TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein and amyloid precursor-like protein 2 have distinct roles in modulating myelination, demyelination, and remyelination of axons. Truong PH; Ciccotosto GD; Merson TD; Spoerri L; Chuei MJ; Ayers M; Xing YL; Emery B; Cappai R Glia; 2019 Mar; 67(3):525-538. PubMed ID: 30506868 [TBL] [Abstract][Full Text] [Related]
11. A unique role for Fyn in CNS myelination. Sperber BR; Boyle-Walsh EA; Engleka MJ; Gadue P; Peterson AC; Stein PL; Scherer SS; McMorris FA J Neurosci; 2001 Mar; 21(6):2039-47. PubMed ID: 11245687 [TBL] [Abstract][Full Text] [Related]
12. Nanostructure-specific X-ray tomography reveals myelin levels, integrity and axon orientations in mouse and human nervous tissue. Georgiadis M; Schroeter A; Gao Z; Guizar-Sicairos M; Liebi M; Leuze C; McNab JA; Balolia A; Veraart J; Ades-Aron B; Kim S; Shepherd T; Lee CH; Walczak P; Chodankar S; DiGiacomo P; David G; Augath M; Zerbi V; Sommer S; Rajkovic I; Weiss T; Bunk O; Yang L; Zhang J; Novikov DS; Zeineh M; Fieremans E; Rudin M Nat Commun; 2021 May; 12(1):2941. PubMed ID: 34011929 [TBL] [Abstract][Full Text] [Related]
13. Reversals of blood-brain barrier disruption by catalase: a serial magnetic resonance imaging study of experimental optic neuritis. Guy J; McGorray S; Fitzsimmons J; Beck B; Mancuso A; Rao NA; Hamed L Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3456-65. PubMed ID: 8056521 [TBL] [Abstract][Full Text] [Related]
14. Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Bouhrara M; Reiter DA; Bergeron CM; Zukley LM; Ferrucci L; Resnick SM; Spencer RG Alzheimers Dement; 2018 Aug; 14(8):998-1004. PubMed ID: 29679574 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system. Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190 [TBL] [Abstract][Full Text] [Related]
17. Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging. Vithanarachchi SM; Foley CD; Trimpin S; Ewing JR; Ali MM; Allen MJ Contrast Media Mol Imaging; 2016 Nov; 11(6):492-505. PubMed ID: 27596704 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance techniques in the assessment of myelin and myelination. Barkovich AJ J Inherit Metab Dis; 2005; 28(3):311-43. PubMed ID: 15868466 [TBL] [Abstract][Full Text] [Related]
20. Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T. Zaaraoui W; Deloire M; Merle M; Girard C; Raffard G; Biran M; Inglese M; Petry KG; Gonen O; Brochet B; Franconi JM; Dousset V MAGMA; 2008 Sep; 21(5):357-62. PubMed ID: 18779984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]